相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Genetic contributions to NAFLD: leveraging shared genetics to uncover systems biology
Mohammed Eslam et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)
FGF21 and the Physiological Regulation of Macronutrient Preference
Cristal M. Hill et al.
ENDOCRINOLOGY (2020)
Redefining non-alcoholic fatty liver disease: what's in a name?
[Anonymous]
LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)
Targeting FGF21 for the Treatment of Nonalcoholic Steatohepatitis
Mohammad Zarei et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2020)
A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
Mohammed Eslam et al.
JOURNAL OF HEPATOLOGY (2020)
A Dozen Years of Discovery: Insights into the Physiology and Pharmacology of FGF21
Steven A. Kliewer et al.
CELL METABOLISM (2019)
Codon and Codon-Pair Usage Tables (CoCoPUTs): Facilitating Genetic Variation Analyses and Recombinant Gene Design
Aikaterini Alexaki et al.
JOURNAL OF MOLECULAR BIOLOGY (2019)
Slowing ribosome velocity restores folding and function of mutant CFTR
Kathryn E. Oliver et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
The ribosomal P-stalk couples amino acid starvation to GCN2 activation in mammalian cells
Heather P. Harding et al.
ELIFE (2019)
Increased plasma FGF21 level as an early biomarker for insulin resistance and metabolic disturbance in obese insulin-resistant rats
Pongpan Tanajak et al.
DIABETES & VASCULAR DISEASE RESEARCH (2018)
Preemptive Activation of the Integrated Stress Response Protects Mice From Diet-Induced Obesity and Insulin Resistance by Fibroblast Growth Factor 21 Induction
Xu Xu et al.
HEPATOLOGY (2018)
A Common Allele in FGF21 Associated with Sugar Intake Is Associated with Body Shape, Lower Total Body-Fat Percentage, and Higher Blood Pressure
Timothy M. Frayling et al.
CELL REPORTS (2018)
Timing during translation matters: synonymous mutations in human pathologies influence protein folding and function
Robert Rauscher et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2018)
Active Ribosome Profiling with RiboLace
Massimiliano Clamer et al.
CELL REPORTS (2018)
The importance of mRNA structure in determining the pathogenicity of synonymous and non-synonymous mutations in haemophilia
N. Hamasaki-Katagiri et al.
HAEMOPHILIA (2017)
Letter to the Editor: Parameters, Characteristics, and Criteria for Defining the Term FGF21 Resistance
Pongpan Tanajak
ENDOCRINOLOGY (2017)
A Unique ISR Program Determines Cellular Responses to Chronic Stress
Bo-Jhih Guan et al.
MOLECULAR CELL (2017)
IFN-λ3, not IFN-λ4, likely mediates IFNL3-IFNL4 haplotype-dependent hepatic inflammation and fibrosis
Mohammed Eslam et al.
NATURE GENETICS (2017)
Insulin action and resistance in obesity and type 2 diabetes
Michael P. Czech
NATURE MEDICINE (2017)
Thiol-linked alkylation of RNA to assess expression dynamics
Veronika A. Herzog et al.
NATURE METHODS (2017)
Fibroblast growth factor 21 (FGF21) is robustly induced by ethanol and has a protective role in ethanol associated liver injury
Bhavna N. Desai et al.
MOLECULAR METABOLISM (2017)
FGF21 resistance is not mediated by downregulation of beta-klotho expression in white adipose tissue
Kathleen R. Markan et al.
MOLECULAR METABOLISM (2017)
A new and updated resource for codon usage tables
John Athey et al.
BMC BIOINFORMATICS (2017)
FGF21 Is a Sugar-Induced Hormone Associated with Sweet Intake and Preference in Humans
Susanna Soberg et al.
CELL METABOLISM (2017)
A Long-Acting FGF21 Molecule, PF-05231023, Decreases Body Weight and Improves Lipid Profile in Non-human Primates and Type 2 Diabetic Subjects
Saswata Talukdar et al.
CELL METABOLISM (2016)
The integrated stress response
Karolina Pakos-Zebrucka et al.
EMBO REPORTS (2016)
Diverse Impacts of the rs58542926 E167K Variant in TM6SF2 on Viral and Metabolic Liver Disease Phenotypes
Mohammed Eslam et al.
HEPATOLOGY (2016)
The macrophage activation marker sCD163 is associated with morphological disease stages in patients with non-alcoholic fatty liver disease
Konstantin Kazankov et al.
LIVER INTERNATIONAL (2016)
FGF21 is a biomarker for mitochondrial translation and mtDNA maintenance disorders
Jenni M. Lehtonen et al.
NEUROLOGY (2016)
Elevated Serum Fibroblast Growth Factor 21 in Humans with Acute Pancreatitis
Vivek K. Shenoy et al.
PLOS ONE (2016)
Human FGF-21 Is a Substrate of Fibroblast Activation Protein
Andrew L. Coppage et al.
PLOS ONE (2016)
Pharmacokinetics and pharmacodynamics of PF-05231023, a novel long-acting FGF21 mimetic, in a first-in-human study
Jennifer Q. Dong et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2015)
The Silent Sway of Splicing by Synonymous Substitutions
William F. Mueller et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Targeting the translation machinery in cancer
Mamatha Bhat et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
Statistics requantitates the central dogma
Jingyi Jessica Li et al.
SCIENCE (2015)
Impact of regulatory variation from RNA to protein
Alexis Battle et al.
SCIENCE (2015)
Circulating FGF21 Is Liver Derived and Enhances Glucose Uptake During Refeeding and Overfeeding
Kathleen R. Markan et al.
DIABETES (2014)
Fibroblast Growth Factor 21 Limits Lipotoxicity by Promoting Hepatic Fatty Acid Activation in Mice on Methionine and Choline-Deficient Diets
Ffolliott M. Fisher et al.
GASTROENTEROLOGY (2014)
Landscape and variation of RNA secondary structure across the human transcriptome
Yue Wan et al.
NATURE (2014)
Genome-wide meta-analysis of observational studies shows common genetic variants associated with macronutrient intake
Toshiko Tanaka et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2013)
Fibroblast growth factor 21 is induced by endoplasmic reticulum stress
Frank G. Schaap et al.
BIOCHIMIE (2013)
Novel locus including FGF21 is associated with dietary macronutrient intake
Audrey Y. Chu et al.
HUMAN MOLECULAR GENETICS (2013)
RNAsnp: Efficient Detection of Local RNA Secondary Structure Changes Induced by SNPs
Radhakrishnan Sabarinathan et al.
HUMAN MUTATION (2013)
Protein synthesis rate is the predominant regulator of protein expression during differentiation
Anders R. Kristensen et al.
MOLECULAR SYSTEMS BIOLOGY (2013)
Autophagy deficiency leads to protection from obesity and insulin resistance by inducing Fgf21 as a mitokine
Kook Hwan Kim et al.
NATURE MEDICINE (2013)
Circulating Fibroblast Growth Factors as Metabolic Regulators-A Critical Appraisal
Bo Angelin et al.
CELL METABOLISM (2012)
The role of glycogen synthase in the development of hyperglycemia in type 2 diabetes - 'To store or not to store glucose, that's the question'
Henning Beck-Nielsen
DIABETES-METABOLISM RESEARCH AND REVIEWS (2012)
Lack of Overt FGF21 Resistance in Two Mouse Models of Obesity and Insulin Resistance
Clarence Hale et al.
ENDOCRINOLOGY (2012)
Fibroblast growth factor 21 promotes bone loss by potentiating the effects of peroxisome proliferator-activated receptor γ
Wei Wei et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
ViennaRNA Package 2.0
Ronny Lorenz et al.
ALGORITHMS FOR MOLECULAR BIOLOGY (2011)
Liver Fat But Not Other Adiposity Measures Influence Circulating FGF21 Levels in Healthy Young Adult Twins
Henna Tyynismaa et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Understanding the contribution of synonymous mutations to human disease
Zuben E. Sauna et al.
NATURE REVIEWS GENETICS (2011)
Codon usage bias and the evolution of influenza A viruses. Codon Usage Biases of Influenza Virus
Emily H. M. Wong et al.
BMC EVOLUTIONARY BIOLOGY (2010)
An Evolutionarily Conserved Mechanism for Controlling the Efficiency of Protein Translation
Tamir Tuller et al.
CELL (2010)
Increased Fibroblast Growth Factor 21 in Obesity and Nonalcoholic Fatty Liver Disease
Jody Dushay et al.
GASTROENTEROLOGY (2010)
Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride
Huating Li et al.
JOURNAL OF HEPATOLOGY (2010)
Circulating Fibroblast Growth Factor-21 Is Elevated in Impaired Glucose Tolerance and Type 2 Diabetes and Correlates With Muscle and Hepatic Insulin Resistance
Alberto O. Chavez et al.
DIABETES CARE (2009)
Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans
Xinmei Zhang et al.
DIABETES (2008)
Activation and dysregulation of the unfolded protein response in nonalcoholic fatty liver disease
Puneet Puri et al.
GASTROENTEROLOGY (2008)
Analytical distributions for stochastic gene expression
Vahid Shahrezaei et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Control of mammalian translation by mRNA structure near caps
JR Babendure et al.
RNA (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Design and validation of a histological scoring system for nonalcoholic fatty liver disease
DE Kleiner et al.
HEPATOLOGY (2005)
The human model: A genetic dissection of immunity to infection in natural conditions
JL Casanova et al.
NATURE REVIEWS IMMUNOLOGY (2004)
分享论文
